ZS Pharma, Inc. (Nasdaq: ZSPH), today confirmed that it has participated in preliminary discussions with Actelion ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE